Magnesium sulfate “remains uncommon” but appropriate for acute asthma Clinical study 02 February 2013 Pages: 3 - 3
Use of drugs under pharmacogenetic influence common in primary care Clinical study 02 February 2013 Pages: 3 - 3
Antiasthmatic use rises but therapy still “far from ideal” Clinical study 02 February 2013 Pages: 4 - 4
Controversial dextropropoxyphene/paracetamol remains widely prescribed in Ireland Clinical study 02 February 2013 Pages: 4 - 4
Lenalidomide cost effective for transfusion-dependent MDS Clinical study 02 February 2013 Pages: 4 - 4
PEG INF-α-2a/ribavirin cost effective for mild-chronic hep C Clinical study 02 February 2013 Pages: 4 - 4
Adefovir dipivoxil better than lamivudine in face of resistance Clinical study 02 February 2013 Pages: 5 - 5
ADR-related costs higher with amoxicillin/clavulanic acid Clinical study 02 February 2013 Pages: 5 - 5
Orlistat weighs in against size of diabetes patients and costs Clinical study 02 February 2013 Pages: 5 - 5
Sequential therapy warranted where combo therapy inappropriate Clinical study 02 February 2013 Pages: 6 - 6
Absolute risk-based hypertension guidelines worth trying in S Africa Clinical study 02 February 2013 Pages: 7 - 7
Significant cost burden from nosocomial catheter-related bloodstream infections Clinical study 02 February 2013 Pages: 7 - 7
Million Women Study sways HRT prescribing in The Netherlands Clinical study 02 February 2013 Pages: 8 - 8
PEG IFN-α-2b/ribavirin cost effective for HIV/HCV co-infection Clinical study 02 February 2013 Pages: 8 - 8
Temozolomide improves survival, no HRQOL loss in glioblastoma Clinical study 02 February 2013 Pages: 9 - 9
WHO receives, calls for aid in avian flu fight in same week News item 02 February 2013 Pages: 10 - 10
FDA warns against filling prescriptions in foreign countries News item 02 February 2013 Pages: 11 - 11